The Walensky Laboratory comprises a multidisciplinary group of young scientists, training as Dana-Farber Cancer Institute postdoctoral fellows in pediatric oncology, graduate students in the chemical and biological sciences graduate programs at Harvard Medical School, and post-baccalaureate research technicians. Our mission is to dissect and target the aberrant molecular pathways that cause treatment resistance in pediatric cancer. In doing so, we work to advance next generation therapies for relapsed and refractory pediatric malignancies.

Please support the running, walking, and cycling efforts of the Walensky Running Buffers in 2025!